Form 8.3 - Allergan plc

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Allergan plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BY9D5467

Date of dealing

24 January 2020

2. INTERESTS AND SHORT POSITIONS

  1. Interests and short positions (following dealing) in the class ofrelevant security dealt in(Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

3,379,825

(1.029%)

1,890
(0.001%)

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

3,379,825

(1.029%)

1,890
(0.001%)

 
  1. Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

3. DEALINGS (Note 4)

  1. Purchases and sales

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

(USD)

Purchase

2,324

188.19

Sale

100

187.89

Sale

100

187.91

Sale

100

187.96

Sale

100

187.97

Sale

100

187.98

Sale

195

188.00

Sale

535

188.02

Sale

200

188.03

Sale

400

188.04

Sale

100

188.07

Sale

100

188.08

Sale

200

188.09

Sale

100

188.10

Sale

201

188.11

Sale

100

188.12

Sale

15

188.13

Sale

404

188.15

Sale

653

188.16

Sale

600

188.17

Sale

100

188.18

Sale

100

188.20

Sale

200

188.22

Sale

867

188.23

Sale

200

188.24

Sale

337

188.28

Sale

100

188.29

Sale

466

188.30

Sale

184

188.33

Sale

100

188.34

Sale

200

188.35

Sale

490

188.36

Sale

100

188.37

Sale

200

188.38

Sale

100

188.39

Sale

100

188.40

Sale

100

188.41

Sale

146

188.42

Sale

100

188.43

Sale

100

188.44

Sale

69

188.46

Sale

442

188.50

Sale

100

188.51

Sale

200

188.53

Sale

200

188.54

Sale

100

188.55

Sale

100

188.57

Sale

100

188.60

Sale

100

188.64

Sale

100

188.66

Sale

100

188.69

Sale

100

188.71

Sale

1

188.72

Sale

1

188.75

Sale

1

188.77

Sale

100

188.78

Sale

100

188.79

Sale

100

188.80

Sale

100

188.83

Sale

100

188.92

Sale

100

188.95

Sale

101

189.01

Sale

200

189.19

Sale

200

189.21

Sale

100

189.25

Sale

100

189.26

Sale

100

189.41

Sale

100

189.47

Sale

100

189.50

Sale

100

189.72

Sale

100

189.75

Purchase

99

187.97

Purchase

215

187.98

Purchase

545

187.99

Purchase

301

188.00

Purchase

300

188.01

Purchase

275

188.02

Purchase

165

188.03

Purchase

117

188.05

Purchase

1,703

188.06

Purchase

1,061

188.07

Purchase

142

188.08

Purchase

346

188.09

Purchase

99

188.10

Purchase

199

188.18

Purchase

3,085

188.19

Purchase

730

188.20

Purchase

1,086

188.21

Purchase

676

188.22

Purchase

2,046

188.23

Purchase

1,325

188.24

Purchase

3,163

188.25

Purchase

1,332

188.26

Purchase

1,026

188.27

Purchase

678

188.28

Purchase

879

188.29

Purchase

194

188.30

Purchase

297

188.31

Purchase

1,243

188.32

Purchase

2,223

188.33

Purchase

995

188.34

Purchase

595

188.35

Purchase

114

188.36

Purchase

246

188.37

Purchase

100

188.39

Purchase

99

188.40

Purchase

49

188.41

Purchase

216

188.42

Purchase

155

188.43

Purchase

100

188.46

Purchase

200

188.49

Purchase

50

188.54

Purchase

12,786

188.62

Purchase

200

188.92

Purchase

19,314

188.95

Purchase

5

188.96

Purchase

100

188.97

Purchase

10

189.43

Sale

1,016

188.19

Sale

751

188.24

Sale

10

188.79

Sale

10

189.52

  1. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

  1. Options transactions in respect of existing relevant securities

ii. Writing, selling, purchasingor varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

iii. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

iv. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

27 January 2020

Contact name

Milos Naumovic

Telephone number

+44 203 650 8203

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

Short Name: MILLENNIUM PARTNERS, L.P.
Category Code: RET
Sequence Number: 691176
Time of Receipt (offset from UTC): 20200127T150542+0000

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.